OKT3 versus methylprednisolone for primary treatment of rejection: a retrospective evaluation.
Meijer
R T
RT
Renal Transplant Unit, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Keur
I
I
Surachno
S
S
ten Berge
I J
IJ
Schellekens
P T
PT
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008775:Methylprednisolone / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D012189:Retrospective Studies
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D003404:Creatinine; D008775:Methylprednisolone